Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00521482
Status:
UNKNOWN
Last Update Posted:
2007-08-28
First Post:
2007-08-27
Brief Title:
Temozolomide vs Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
Sponsor:
University of Zurich
Organization:
University of Zurich
Organization Data
Organization:
University of Zurich
Class:
OTHER
Study ID:
TMZ05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Zurich
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None